Graham Capital Management, L.P. Syndax Pharmaceuticals Inc Transaction History
Graham Capital Management, L.P.
- $4.42 Billion
- Q3 2024
A detailed history of Graham Capital Management, L.P. transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Graham Capital Management, L.P. holds 57,939 shares of SNDX stock, worth $825,051. This represents 0.03% of its overall portfolio holdings.
Number of Shares
57,939
Previous 75,651
23.41%
Holding current value
$825,051
Previous $1.55 Million
28.2%
% of portfolio
0.03%
Previous 0.05%
Shares
4 transactions
Others Institutions Holding SNDX
# of Institutions
229Shares Held
90MCall Options Held
1.01MPut Options Held
692K-
Black Rock Inc. New York, NY7.91MShares$113 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.84MShares$83.2 Million9.23% of portfolio
-
Wellington Management Group LLP Boston, MA4.99MShares$71 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.89MShares$69.6 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY4.11MShares$58.5 Million6.25% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $805M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...